Exane Derivatives’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,301
Closed -$50.6K 1051
2021
Q1
$50.6K Buy
+1,301
New +$50.6K 0.01% 500